Sabrina Apitz-Grossman, a 28-year-old who was previously healthy and happy, received an unexpected cancer diagnosis three years ago, which has dramatically altered her life. Initially misdiagnosed with a hamstring injury, she learned that cancer had developed in her knee. This shocking revelation marked the beginning of a two-fold battle: the fight against cancer itself and a struggle to access the treatment she desperately needs.
Apitz-Grossman was informed by her doctors that the best treatment option, Tecelra, was available only in the United States. This personalized therapy utilizes the patient's own T-cells, a type of white blood cell, and exhibits a strong response rate, with nearly 50% of patients experiencing positive outcomes. According to her oncologist, the survival rates for those who respond to the treatment are impressive, with a 90% chance of survival after one year and 70% after two years. However, the staggering cost of the treatment, approximately US$727,000, presents a significant barrier.
Ontario Health’s expert reviews recommended the out-of-country treatment option, stating that it was worth pursuing. Despite this, Apitz-Grossman received an official letter from the Ministry of Health denying her application. The disheartening situation left her feeling frustrated, as she noted that numerous consultations indicated that the treatment was feasible, yet the bureaucratic system prevented her from accessing it. “Everyone who’s consulted says yes,” Apitz-Grossman explained, “and yet you can’t get your hands on it. You can’t put your finger on it. You can’t access it.”
In a recent development that highlighted the severity of her situation, Apitz-Grossman's struggle was brought to the forefront of the legislature, where Member of Provincial Parliament (MPP) Robin Lennox was removed by the Speaker after publicly accusing the health minister of dishonesty regarding Apitz-Grossman’s treatment eligibility. Lennox reiterated that the health experts had affirmed Apitz-Grossman’s need for the treatment, asserting that she possessed written confirmation contradicting the health minister's claims.
In response to the legislative uproar, Health Minister Sylvia Jones maintained that the decisions made regarding treatment approvals were grounded in expert assessment, dismissing the accusations as politically motivated. Liberal critic Adil Shamji emphasized the negative impact of these delays, stating that each appeal results in further delays that jeopardize the health of patients like Apitz-Grossman.
Despite ongoing challenges and bureaucratic setbacks, Apitz-Grossman remains determined to fight for her right to access the treatment she requires. Drawing from her resolve, she expressed her aspirations for the future, saying, “You have this shot at life. I could see my 40th birthday. I could see my 50th. I could turn 90.” Her case has taken a legal turn, as she plans to pursue court action following the denial of her appeal by the province's health services review board. The urgency of her situation has expedited her case, which is scheduled to be heard in less than a few weeks.
As Apitz-Grossman continues to navigate her complex battle against cancer and the healthcare system, her story serves as a powerful testament to the challenges faced by patients seeking life-saving treatments amid bureaucratic obstacles.
